Key financial indicators
Overview of key financial indicators in 1-3 2017
| Sales (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 915.5 | 1,002.9 | -8.7% |
| Sales revenues of Podravka Group | 913.2 | 997.1 | -8.4% |
| Sales revenues of SBA Food | 723.6 | 814.6 | -11.2% |
| Sales revenues of SBA Pharma | 189.6 | 182.5 | 3.9% |
| Podravka Group's profitability (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
| Group's gross profit | 320.6 | 365.5 | -12.3% |
| Group's gross profit margin | 35.1% | 36.7% | -154 bp |
| Group's EBITDA | 75.8 | 126.9 | -40.3% |
| Group's EBITDA margin | 8.3% | 12.7% | -442 bp |
| Group's EBIT | 28.2 | 81.1 | -65.2% |
| Group's EBIT margin | 3.1% | 8.1% | -504 bp |
| Group's net profit after MI | 18.0 | 60.1 | -70.0% |
| Group's net profit margin after MI | 2.0% | 6.0% | -405 bp |
| Podravka Group's balance sheet (in HRKm) | 31.03.2017 | 31.12.2016 | % change |
| Total assets | 5,182.2 | 5,285.7 | -2.0% |
| Shareholders' equity | 2,890.0 | 2,877.2 | 0.4% |
| Minority interests | 50.2 | 49.2 | 2.0% |
| Cash and cash equivalents | 250.5 | 337.6 | -25.8% |
| Financial debt | 1,338.1 | 1,379.4 | -3.0% |
| Net debt | 1,087.6 | 1,041.7 | 4.4% |
| Podravka Group's cash flow (in HRKm) | 1-3 2017 | 1-3 2016 | % change |
| Net cash flow from operating activities | 48.1 | -5.0 | n/a |
| Capital expenditures | 84.7 | 121.1 | -30.0% |
| Depreciation and amortization | 47.6 | 45.8 | 3.9% |
| Free cash flow | -36.6 | -126.0 | -71.0% |
| Podravka Group's ratios and indicators | 31.03.2017 | 2016 | % change |
| Employee number as at 31.12. (in units) | 6,497 | 6,404 | 1.5% |
| P&L interest expense | 29.4 | 31.5 | -6.5% |
| Sales revenues / Number of employees (in HRK000) | 631.3 | 653.6 | -3.4% |
| Net profit after MI / Sales revenues (in HRK000) | 21.6 | 28.5 | -24.2% |
| Return on average assets | 2.8% | 3.7% | -83 bp |
| Return on average capital | 5.0% | 6.5% | -150 bp |
| Return on average invested capital | 4.3% | 5.6% | -126 bp |
| Total shareholders' equity / Total assets | 56.7% | 55.4% | +137 bp |
| EBITDA / P&L interest expense | 14.2 | 14.9 | -4.7% |
| Net debt / EBITDA | 2.6 | 2.2 | 17.1% |
| Sales (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,226.5 | 3,761.1 | 12.4% |
| Sales revenues of Podravka Group | 4,185.5 | 3,626.8 | 15.4% |
| Sales revenues of SBA Food | 3,370.3 | 2,821.8 | 19.4% |
| Sales revenues of SBA Pharma | 815.2 | 805.0 | 1.3% |
| Podravka Group's profitability (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
| Group's gross profit | 1,518.9 | 1,385.1 | 9.7% |
| Group's gross profit margin | 36.3% | 38.2% | -190 bb |
| Group's EBITDA | 469.6 | 468.6 | 0.2% |
| Group's EBITDA margin | 11.2% | 12.9% | -170 bb |
| Group's EBIT | 268.9 | 285.2 | -5.7% |
| Group's EBIT margin | 6.4% | 7.9% | -144 bb |
| Group's net profit after MI | 182.4 | 397.3 | -54.1% |
| Group's net profit margin after MI | 4.4% | 11.0% | -660 bb |
| Podravka Group's balance sheet (in HRKm) | 31.12.2016 | 31.12.2015 | % change |
| Total assets | 5,285.7 | 4,991.6 | 5.9% |
| Shareholders' equity | 2,877.2 | 2,750.0 | 4.6% |
| Minority interests | 49.2 | 67.7 | -27.3% |
| Cash and cash equivalents | 337.6 | 291.9 | 15.7% |
| Financial debt | 1,379.4 | 1,214.3 | 13.6% |
| Net debt | 1,041.7 | 922.4 | 12.9% |
| Podravka Group's cash flow (in HRKm) | 1-12 2016 | 1-12 2015 | % change |
| Net cash flow from operating activities | 476.7 | 274.2 | 73.8% |
| Capital expenditures | 437.1 | 271.2 | 61.2% |
| Depreciation and amortization | 191.4 | 148.3 | 29.1% |
| Free cash flow | 39.6 | 3.0 | 1226.2% |
| Podravka Group's ratios and indicators | 2016 | 2015 | % change |
| Employee number as at 31.12. (in units) | 6,404 | 6,657 | -3.8% |
| P&L interest expense | 31.5 | 36.9 | -14.8% |
| Sales revenues / Number of employees (in HRK000) | 653.6 | 544.8 | 20.0% |
| Net profit after MI / Sales revenues (in HRK000) | 28.5 | 59.7 | -52.3% |
| Return on average assets | 3.5% | 9.3% | -580 bb |
| Return on average capital | 6.5% | 17.7% | -1118 bb |
| Return on average invested capital | 5.6% | 7.1% | -157 bb |
| Total shareholders' equity / Total assets | 55.4% | 56.5% | -109 bb |
| EBITDA / P&L interest expense | 15.2 | 12.7 | 19.5% |
| Net debt / EBITDA | 2.2 | 2.0 | 10.9% |
| Sales (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,044.3 | 2,503.6 | 21.6% |
| Sales revenues of Podravka Group | 3,030.8 | 2,462.2 | 23.1% |
| Sales revenues of SBA Food | 2,465.2 | 1,897.8 | 29.9% |
| Sales revenues of SBA Pharma | 565.7 | 564.3 | 0.2% |
| Podravka Group's profitability (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
| Group's gross profit | 1,104.1 | 957.2 | 15.3% |
| Group's gross profit margin | 36.4% | 38.9% | -245 bp |
| Group's EBITDA | 337.4 | 276.5 | 22.0% |
| Group's EBITDA margin | 11.1% | 11.2% | -10 bp |
| Group's EBIT | 201.2 | 166.8 | 20.6% |
| Group's EBIT margin | 6.6% | 6.8% | -14 bp |
| Group's net profit after MI | 142.2 | 131.0 | 8.6% |
| Group's net profit margin after MI | 4.7% | 5.3% | -63 bp |
| Podravka Group's balance sheet (in HRKm) | 30.09.2016 | 31.12.2015 | % change |
| Total assets | 5,082.4 | 4,945.8 | 2.8% |
| Shareholders' equity | 2,828.3 | 2,750.0 | 2.8% |
| Minority interests | 48.2 | 67.7 | -28.8% |
| Cash and cash equivalents | 219.4 | 291.9 | -24.8% |
| Financial debt | 1,375.0 | 1,214.3 | 13.2% |
| Net debt | 1,155.6 | 922.4 | 25.3% |
| Podravka Group's cash flow (in HRKm) | 1-9 2016 | 1-9 2015 | % change |
| Net cash flow from operating activities | 299.3 | 32.3 | 826.9% |
| Capital expenditures | 383.7 | 144.7 | 165.2% |
| Depreciation and amortization | 136.1 | 101.2 | 34.5% |
| Free cash flow | (84.4) | (112.4) | -24.9% |
| Podravka Group's ratios and indicators | 1-9 2016. | 2015 | % change |
| Employee number as at 31.12. (in units) | 6,754 | 6,657 | 1.5% |
| P&L interest expense | 35.0 | 36.9 | -5.2% |
| Sales revenues / Number of employees (in HRK000) | 621.2 | 544.8 | 14.0% |
| Net profit after MI / Sales revenues (in HRK000) | 60.5 | 59.7 | 1.3% |
| Return on average assets | 8.1% | 9.4% | -125 bp |
| Return on average capital | 14.6% | 17.7% | -302 bp |
| Return on average invested capital | 6.6% | 7.2% | -57 bp |
| Total shareholders' equity / Total assets | 56.6% | 57.0% | -38 bp |
| EBITDA / P&L interest expense | 15.1 | 12.7 | 19.2% |
| Net debt / EBITDA | 2.2 | 2.0 | 10.9% |
| Sales (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,998.4 | 1,613.7 | 23.8% |
| Sales revenues of Podravka Group | 1,988.5 | 1,576.3 | 26.2% |
| Sales revenues of SBA Food | 1,609.5 | 1,198.7 | 34.3% |
| Sales revenues of SBA Pharma | 379.1 | 377.6 | 0.4% |
| Podravka Group's profitability (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
| Group's gross profit | 723.8 | 614.3 | 17.8% |
| Group's gross profit margin | 36.4% | 39.0% | -257 bp |
| Group's EBITDA | 222.0 | 196.1 | 13.2% |
| Group's EBITDA margin | 11.2% | 12.4% | -128 bp |
| Group's EBIT | 129.8 | 123.2 | 5.4% |
| Group's EBIT margin | 6.5% | 7.8% | -129 bp |
| Group's net profit after MI | 97.3 | 91.9 | 5.8% |
| Group's net profit margin after MI | 4.9% | 5.8% | -94 bp |
| Podravka Group's balance sheet (in HRKm) | 30.06.2016 | 31.12.2015 | % change |
| Total assets | 4,947.9 | 4,945.8 | 0.0% |
| Shareholders' equity | 2,835.3 | 2,750.0 | 3.1% |
| Minority interests | 46.6 | 67.7 | -31.2% |
| Cash and cash equivalents | 242.2 | 291.9 | -17.0% |
| Financial debt | 1,264.3 | 1,214.3 | 4.1% |
| Net debt | 1,022.1 | 922.4 | 10.8% |
| Podravka Group's cash flow (in HRKm) | 1-6 2016 | 1-6 2015 | % change |
| Net cash flow from operating activities | 142.0 | (11.9) | n/a |
| Capital expenditures | 233.1 | 60.6 | 284.7% |
| Depreciation and amortization | 92.2 | 67.3 | 36.9% |
| Free cash flow | (91.1) | (72.5) | 25.6% |
| Podravka Group's ratios and indicators | 1-6 2016 | 2015 | % change |
| Employee number as at 31.12. (in units) | 6,672 | 6,657 | 0.2% |
| P&L interest expense | 35.6 | 36.9 | -3.6% |
| Sales revenues / Number of employees (in HRK000) | 605.4 | 544.8 | 11.1% |
| Net profit after MI / Sales revenues (in HRK000) | 60.4 | 59.7 | 1.1% |
| Return on average assets | 8.1% | 9.4% | -126 bp |
| Return on average capital | 14.4% | 17.7% | -324 bp |
| Return on average invested capital | 6.1% | 7.2% | -104 bp |
| Total shareholders' equity / Total assets | 58.2% | 57.0% | +127 bp |
| EBITDA / P&L interest expense | 13.9 | 12.7 | 9.4% |
| Net debt / EBITDA | 2.1 | 2.0 | 5.0% |
Notes:
Possible decimal differences due to rounding.
Financial debt = Non-current and current borrowings + Financial liabilities at fair value through profit and loss.
Net debt = Financial debt - Cash and cash equivalents.
Free cash flow = Net cash flow from operating activities - Capital expenditures.
Return on average assets = Net profit after minority interests / Average total assets.
Return on average equity = Net profit after minority interests / Average shareholders' equity.
Return on average invested capital = EBIT*0.8 / (Average total shareholders' equity + average financial debt - average cash and cash equivalents).
Ratios and indicators have been calculated on the TTM basis.
